Skip to main content

Table 3 Clinical findings comparing Covid-19 year with the two preceding years regarding abscess localization, presence of desolate dental status, length of hospitalization and ICU stay, and time to treatment

From: The COVID-19 pandemic and its possible impact on the treatment of odontogenic and intraoral abscesses

Clinical findings

Preceding years

n = 663 (%)

Covid-19 year

n = 298 (%)

Abscess type and location

 Pericoronitis-abscess

5 (0.8)

1 (0.3)

 Apical periodontitis/ Periimplantitis-abscess

23 (3.5)

14 (4.7)

 Enosseal abscess

1 (0.1)

0 (0)

 Subperiosteal abscess

18 (2.7)

17 (5.7)

 Submucosal abscess

52 (7.8)

16 (5.4)

 Fossa canaina abscess

130 (19.6)

64 (21.5)

 Parotid abscess

1 (0.1)

0 (0)

 Lip abscess

4 (0.6)

0 (0)

 Tongue abscess

2 (0.3)

0 (0)

 Palatinal abscess

5 (0.8)

5 (1.7)

 Buccal abscess

45 (6.8)

19 (6.4)

 Retromaxillary abscess

0 (0)

2 (0.7)

 Chin abscess

5 (0.8)

0 (0)

 Paramandibular abscess

170 (25.6)

57 (19.1)

 Perimandibular abscess

91 (13.7)

61 (20.5)

 Sublingual abscess

26 (3.9)

9 (3.0)

 Submental abscess

13 (2.0)

6 (2.0)

 Submandibular abscess

35 (5.3)

8 (2.7)

 Masseterico-/pterygomandibular abscess

15 (2.3)

6 (2.0)

 Para-/retropharyngeal abscess

3 (0.5)

1 (0.3)

 Several lodges abscess

1 (0.1)

3 (1.0)

 Not other specified abscess

18 (2.7)

9 (3.0)

Desolate dental chart

171 (25.8)

109 (36.6)

Hospitalisation (days)

mean 6 (1–51)

mean 6 (1–50)

Length of ICU stay (days)

mean 10 (1–27)

mean 5 (1–12)

Time to treatment (days)

mean 7 (1–270)

mean 8 (1–320)

Potentially life-threatening cases

(ICU patients) n = 25

Preceding years

n = 17 (68)

Covid-19 year

n = 8 (32)

Massive pharyngeal swelling (potentially life-threatening)

11 (44)

7 (28)

Dysphagia

1 (4)

0 (0)

Oxygen saturation drop

2 (8)

0 (0)

Acute kidney disease

0 (0)

1 (4)

Mediastinitis

1 (4)

0 (0)

Sepsis

2 (8)

0 (0)